The need for improved risk stratification in chronic critical limb ischemia
- 1 December 2014
- journal article
- review article
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 60 (6), 1677-1685
- https://doi.org/10.1016/j.jvs.2014.07.104
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategyJournal of Vascular Surgery, 2010
- Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemiaJournal of Vascular Surgery, 2009
- Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomesJournal of Vascular Surgery, 2007
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Journal of Vascular Surgery, 2007
- Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularizationJournal of Vascular Surgery, 2006
- Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgeryJournal of Vascular Surgery, 2006
- Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trialThe Lancet, 2005
- Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary CareJama-Journal Of The American Medical Association, 2001
- Recommended standards for reports dealing with lower extremity ischemia: Revised versionJournal of Vascular Surgery, 1997